Literature DB >> 29581214

Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial).

Nadia A Khan1, Simon W Rabkin2, Yinshan Zhao2, Finlay A McAlister2, Julie E Park2, Meijiao Guan2, Sammy Chan2, Karin H Humphries2.   

Abstract

Systolic and diastolic blood pressure thresholds, below which cardiovascular events increase, are widely debated. Using data from the SPRINT (Systolic Blood Pressure Intervention Trial), we evaluated the relation between systolic and diastolic pressure and cardiovascular events among 1519 participants with or 7574 without prior cardiovascular disease. Using Cox regression, we examined the composite risk of myocardial infarction, other acute coronary syndrome, stroke, heart failure, or cardiovascular death, and follow-up systolic and diastolic pressure were analyzed as time-dependent covariates for a median of 3.1 years. Models were adjusted for age, sex, baseline systolic pressure, body mass index, 10-year Framingham risk score, and estimated glomerular filtration rate. A J-shaped relationship with diastolic pressure was observed in both treatment arms in patients with or without cardiovascular disease (P nonlinearity≤0.002). When diastolic pressure fell <55 mm Hg, the hazards were at least 25% higher relative to 70 mm Hg (P=0.29). The hazard ratios (95% CI) of diastolic pressure <55 mm Hg versus 55 to 90 mm Hg were 1.68 (1.16-2.43), P value 0.006 and 1.52 (0.99-2.34), P value 0.06 in patients without and with prior cardiovascular disease, respectively. After adjusting for follow-up diastolic pressure, follow-up systolic pressure was not associated with the outcome in those without prior cardiovascular disease (P=0.64). In those with cardiovascular disease, adjusting for diastolic pressure, follow-up systolic pressure was associated with the risk in the intensive arm (hazard ratio per 10 mm Hg decrease, 0.86; 95% CI, 0.75-0.99; P interaction=0.02). Although the observed J-shaped relationship may be because of reverse causality in the SPRINT population, we advise caution in aggressively lowering diastolic pressure.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  blood pressure; cardiovascular disease; heart failure; hypertension; myocardial infarction

Mesh:

Substances:

Year:  2018        PMID: 29581214     DOI: 10.1161/HYPERTENSIONAHA.117.10177

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  12 in total

Review 1.  Unsolved Problem: (Isolated) Systolic Hypertension with Diastolic Blood Pressure below the Safety Margin.

Authors:  Goran Koracevic; Milovan Stojanovic; Tomislav Kostic; Dragan Lovic; Miloje Tomasevic; Ruzica Jankovic-Tomasevic
Journal:  Med Princ Pract       Date:  2020-05-07       Impact factor: 1.927

2.  Diastolic blood pressure predicts coronary plaque volume in patients with coronary artery disease.

Authors:  Mohamad Saleh; Abdulhamied Alfaddagh; Tarec K Elajami; Hasan Ashfaque; Huzifa Haj-Ibrahim; Francine K Welty
Journal:  Atherosclerosis       Date:  2018-07-29       Impact factor: 5.162

3.  Low Diastolic Blood Pressure and Mortality in Older Women. Results From the Women's Health Initiative Long Life Study.

Authors:  Bernhard Haring; Aileen P McGinn; Victor Kamensky; Matthew Allison; Marcia L Stefanick; Peter F Schnatz; Lewis H Kuller; Jeffrey S Berger; Karen C Johnson; Nazmus Saquib; Lorena Garcia; Phyllis A Richey; JoAnn E Manson; Michael Alderman; Sylvia Wassertheil-Smoller
Journal:  Am J Hypertens       Date:  2022-09-01       Impact factor: 3.080

4.  Response by Beddhu et al to Letters Regarding Article, "Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control".

Authors:  Srinivasan Beddhu; Glenn M Chertow; Alfred K Cheung; William C Cushman; Tom Greene; Guo Wei; Robert Boucher; Paul K Whelton
Journal:  Circulation       Date:  2018-06-12       Impact factor: 29.690

5.  Determination of optimal on-treatment diastolic blood pressure range using automated measurements in subjects with cardiovascular disease-Analysis of a SPRINT trial subpopulation.

Authors:  Piotr Sobieraj; Jacek Lewandowski; Maciej Siński; Zbigniew Gaciong
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-06       Impact factor: 3.738

6.  Orthostatic hypotension and cardiovascular outcomes: Should we be concerned?

Authors:  Steven G Chrysant
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-10       Impact factor: 3.738

7.  Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.

Authors:  Jingen Li; Virend K Somers; Xiang Gao; Zhuo Chen; Jianqing Ju; Qian Lin; Essa A Mohamed; Shahid Karim; Hao Xu; Lijing Zhang
Journal:  JAMA Netw Open       Date:  2021-02-01

Review 8.  Updates in Hypertension Studies According to the Main Clinical Trials: A Review of the Past 45 Years about Pharmaceutical Intervention Effects.

Authors:  Jose Manuel Martínez-Linares
Journal:  Nurs Rep       Date:  2020-09-08

Review 9.  Evaluating the adverse outcome of subtypes of heart failure with preserved ejection fraction defined by machine learning: A systematic review focused on defining high risk phenogroups.

Authors:  Simon W Rabkin
Journal:  EXCLI J       Date:  2022-02-22       Impact factor: 4.068

10.  Risk Stratification by Coronary Perfusion Pressure in Left Ventricular Systolic Dysfunction Patients Undergoing Revascularization: A Propensity Score Matching Analysis.

Authors:  Ming-Jer Hsieh; Chun-Chi Chen; Dong-Yi Chen; Cheng-Hung Lee; Ming-Yun Ho; Jih-Kai Yeh; Yu-Chang Huang; Yu-Ying Lu; Chieh-Yu Chang; Chao-Yung Wang; Shang-Hung Chang; I-Chang Hsieh
Journal:  Front Cardiovasc Med       Date:  2022-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.